Currently, HNF1A gene variants are associated with maturity onset diabetes of the young (MODY) [14, 15], C-reactive protein (CRP) levels [16–18], gamma-glutamyl transferase (GGT) levels [19, 20], total cholesterol (TC) levels [21], pancreatic cancer [22], coronary artery disease [21, 23], and metabolic syndrome (MS) [24]. This evidence concerns the gene CRP and maturity-onset diabetes of the young.